Physician

Debby Chuang

According to 2025 Medicare claims, Debby Chuang (NPI: 1518100460) practices urology in the Billings, MT market, with the plurality of this provider's patient population coming from Yellowstone, MT. This provider's primary affiliated billing organization is SCL HEALTH MEDICAL GROUP - BILLINGS LLC (NPI: 1508289703; TIN: 464056262) and primary practice location at 59101-3519. Chuang is affiliated with the Rocky Mountain Accountable Health Network, Inc (ACO ID: A2217), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Chuang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 447 traditional Medicare patients, billed 3,315 HCPCS/CPT codes, and received $226,303 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,897 prescription claims across 385 beneficiaries totaling $166,692 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 43 claims. Open Payments data shows 2 records totaling $157. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $26,169 and ending at $226,303. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,289 and ending at $166,692. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	148	401	$26,169
2016	636	2,492	$180,031
2017	782	3,681	$270,812
2018	905	4,015	$296,331
2019	857	3,036	$214,391
2020	185	896	$53,284
2021	281	1,125	$80,119
2022	343	1,161	$76,592
2023	423	1,769	$149,428
2024	447	3,315	$226,303

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	277	$9,289
2016	538	2,093	$201,670
2017	699	3,208	$279,433
2018	886	4,502	$485,051
2019	863	4,052	$520,064
2020	373	1,210	$112,656
2021	357	1,490	$103,438
2022	424	1,809	$155,296
2023	421	1,416	$153,875
2024	385	1,897	$166,692

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	36	72	$12,179
2017	47	108	$29,152
2018	31	91	$28,799
2019	14	68	$12,714
2020	N/R	32	$7,267
2021	N/R	29	$5,313
2022	N/R	45	$7,293
2023	N/R	36	$7,427
2024	N/R	43	$7,358

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	162	229	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	288	496	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	154	207	$64
51798	Ultrasound measurement of bladder capacity after voiding	342	735	$8
81003	Automated urinalysis test	123	169	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	126	5,473	$82,692
Gemtesa	Vibegron	35	1,890	$29,347
Solifenacin Succinate	Solifenacin Succinate	197	10,152	$7,859
Tolterodine Tartrate Er	Tolterodine Tartrate	103	5,140	$5,109
Tamsulosin Hcl	Tamsulosin Hcl	308	21,101	$4,974

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	43	$7,358

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$157	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Debby Chuang?

Tedicare shows public-source Medicare data for Debby Chuang (NPI 1518100460), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Debby Chuang have ACO affiliation data?

Debby Chuang is shown with ACO affiliation data for Rocky Mountain Accountable Health Network, Inc (MSSP, ACO ID A2217), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Debby Chuang?

Debby Chuang is linked to SCL HEALTH MEDICAL GROUP - BILLINGS LLC (billing NPI 1508289703) in the available physician profile data.

Does Debby Chuang have Open Payments data?

Debby Chuang has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.